Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.9883
-0.0217 (-2.15%)
At close: Dec 18, 2025, 4:00 PM EST
1.050
+0.062 (6.24%)
After-hours: Dec 18, 2025, 7:11 PM EST
Evogene Market Cap
Evogene has a market cap or net worth of $9.08 million as of December 18, 2025. Its market cap has decreased by -16.56% in one year.
Market Cap
9.08M
Enterprise Value
11.84M
1-Year Change
-16.56%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $9.08M, a decrease of -67.60%. That is a compound annual growth rate of -6.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 9.08M | -30.19% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | 170.86M | 335.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.99B |
| Johnson & Johnson | 504.27B |
| AbbVie | 395.31B |
| UnitedHealth Group | 302.73B |
| AstraZeneca | 281.22B |
| Novartis AG | 259.57B |
| Merck & Co. | 243.91B |
| Abbott Laboratories | 220.59B |